Report cover image

NA Acute Respiratory Distress Syndrome (ARDS) Treatment Market

Publisher Data Bridge Market Research
Published Oct 01, 2023
Length 146 Pages
SKU # DAABD18360467

Description

NA Acute Respiratory Distress Syndrome (ARDS) Treatment Market


The North America acute respiratory distress syndrome (ARDS) treatment market is expected to reach USD 4,096,703.49 thousand by 2030, from USD 1,807,544.80 thousand in 2022, growing at the CAGR of 11.2% in the forecast period of 2023 to 2030.
Market Segmentation
North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type (Mechanical Ventilation, Corticosteroids, Antiviral Medication, Extracorporeal Membrane Oxygenation (ECMO), Tocilizumab, and Others), Cause ( Sepsis, Inhalation of Harmful Substances, Severe Pneumonia, and Others), Route of Administration (Parenteral, Oral, and Others), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country ( U.S., Canada, and Mexico) - Industry Trends and Forecast to 2030

Overview of North America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Dynamics
Driver
• Increasing prevalence and incidence of acute lung injury in the market

Restraint

• High cost of device and treatment

Opportunity

• Strategic initiatives joined with new product launches by market players
Market Players

Some of the major market players operating in the North America Acute Respiratory Distress Syndrome (ARDS) treatment market are listed below:
• Gilead Sciences, Inc.
• Terumo Medical Corporation
• Getinge .
• LivaNova PLC
• Medtronic
• ResMed
• Fisher & Paykel Healthcare Limited.
• Drägerwerk AG & Co. KGaA
• NIPRO
• Fresenius SE & Co. KGaA
• Hamilton Medical
• Pfizer Inc.
• WEINMANN Emergency Medical Technology GmbH + Co. KG
• EUROSETS
• Armstrong Medical
• nice Neotech Medical Systems Pvt. Ltd.
• Besmed Health Business Corp.

Table of Contents

146 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Acute Respiratory Distress Syndrome (Ards) Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces
4.3 Insurance Reimbursement
4.3.1 Center For Medicare Services (Cms)–elso (Extracorporeal Life Support Organization)
4.3.2 Health Resources And Services Administration
4.3.3 Abbott Coding Guide For Ecmo
4.3.4 Central Government Health Scheme (Cghs)
4.3.5 Cern Health Insurance Scheme
4.3.6 American Society Of Clinical Oncology (Asco) – (Medicare & Medicaid)
4.3.7 American Hospital Association
4.4 Pipeline Analysis
4.5 Pricing Analysis
5 Market Overview
5.1 Drivers
5.1.1 Increasing Prevalence And Incidence Of Acute Lung Injury
5.1.2 Wide Range Of Risk Factors For Ards Treatment
5.1.3 Rising Rate Of Air Pollution And Unhealthy Lifestyle
5.1.4 Increasing Accident Rates And Trauma Causing Ards
5.2 Restraints
5.2.1 Complications Associated With The Treatment
5.2.2 High Cost Of Devices And Treatment
5.3 Opportunities
5.3.1 Rising Healthcare Expenditure To Improve Treatment Facilities
5.3.2 Strategic Initiatives Joined With New Product Launch By Market Players
5.3.3 Improving Awareness Regarding Ard Syndrome
5.4 Challenges
5.4.1 Stringent Rules & Regulations
5.4.2 Multiple Challenges Faced By Icu Staff
6 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type
6.1 Overview
6.2 Mechanical Ventilation
6.2.1 High-flow Nasal O2
6.2.2 Bi-level Positive Airway Pressure
6.2.3 Continuous Positive Airway Pressure
6.2.4 Prone Position Ventilation
6.2.5 Others
6.3 Corticosteroids
6.3.1 Methylprednisolone
6.3.2 Dexamethasone
6.3.3 Others
6.4 Antiviral Medication
6.4.1 Ribavirin
6.4.2 Oseltamivir
6.4.3 Others
6.5 Extracorporeal Membrane Oxygenation (Ecmo)
6.6 Tocilizumab
6.7 Others 7 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause
7.1 Overview
7.2 Sepsis
7.3 Inhalation Of Harmful Substances
7.4 Severe Pneumonia
7.5 Others
8 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration
8.1 Overview
8.2 Parenteral
8.2.1 Intravenous
8.2.2 Intramuscular
8.3 Oral
8.4 Others
9 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User
9.1 Overview
9.2 Hospitals
9.3 Specialty Clinics
9.4 Home Healthcare
9.5 Others
10 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel
10.1 Overview
10.2 Direct Tender
10.3 Hospital Pharmacy
10.4 Retail Pharmacy
10.5 Online Pharmacy
11 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region
11.1 North America
11.1.1 U.S.
11.1.2 Canada
11.1.3 Mexico
12 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, Company Landscape
12.1 Company Share Analysis: North America
13 Swot Analysis
14 North America Acute Respiratory Distress Syndrome (Ards) Treatment, Cps
14.1 Gilead Sciences Inc.
14.1.1 Company Snapshot
14.1.2 Revenue Analysis
14.1.3 Company Share Analysis
14.1.4 Product Portfolio
14.1.5 Recent Development
14.2 Terumo Corporation
14.2.1 Company Snapshot
14.2.2 Revenue Analysis
14.2.3 Company Share Analysis
14.2.4 Product Portfolio
14.2.5 Recent Development
14.3 Getinge
14.3.1 Company Snapshot
14.3.2 Revenue Analysis
14.3.3 Company Share Analysis
14.3.4 Product Portfolio
14.3.5 Recent Development
14.4 Livanova Plc
14.4.1 Company Snapshot
14.4.2 Revenue Analysis
14.4.3 Company Share Analysis
14.4.4 Product Portfolio
14.4.5 Recent Developments
14.5 Medtronic
14.5.1 Company Snapshot
14.5.2 Revenue Analysis
14.5.3 Company Share Analysis
14.5.4 Product Portfolio
14.5.5 Recent Developments 14.6 Armstrong Medical
14.6.1 Company Snapshot
14.6.2 Product Portfolio
14.6.3 Recent Development
14.7 Besmed Health Business Corp.
14.7.1 Company Snapshot
14.7.2 Product Portfolio
14.7.3 Recent Developments
14.8 Drägerwerk Ag & Co. Kgaa
14.8.1 Company Snapshot
14.8.2 Revenue Analysis
14.8.3 Product Portfolio
14.8.4 Recent Developments
14.9 Eurosets
14.9.1 Company Snapshot
14.9.2 Product Portfolio
14.9.3 Recent Development
14.10 Fisher & Paykel Healthcare Limited
14.10.1 Company Snapshot
14.10.2 Revenue Analysis
14.10.3 Product Portfolio
14.10.4 Recent Developments
14.11 Fresenius Se & Co. Kgaa.
14.11.1 Company Snapshot
14.11.2 Revenue Analysis
14.11.3 Product Portfolio
14.11.4 Recent Development
14.12 Hamilton Medical
14.12.1 Company Snapshot
14.12.2 Product Portfolio
14.12.3 Recent Development
14.13 Nice Neotech Medical Systems Pvt.Ltd.
14.13.1 Company Snapshot
14.13.2 Product Portfolio
14.13.3 Recent Development
14.14 Nipro
14.14.1 Company Snapshot
14.14.2 Revenue Analysis
14.14.3 Product Portfolio
14.14.4 Recent Development
14.15 Pfizer Inc.
14.15.1 Company Snapshot
14.15.2 Revenue Analysis
14.15.3 Product Portfolio
14.15.4 Recent Development
14.16 Resmed
14.16.1 Company Snapshot
14.16.2 Revenue Analysis
14.16.3 Product Portfolio
14.16.4 Recent Development
14.17 Weinmann Emergency Medical Technology Gmbh + Co. Kg
14.17.1 Company Snapshot
14.17.2 Product Portfolio
14.17.3 Recent Development
15 Questionnaire
16 Related Reports
List Of Tables
Table 1 List Of Prices For Approved Drugs For Acute Respiratory Distress Syndrome (Ards) Treatment
Table 2 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 3 North America Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 4 North America Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 5 North America Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 6 North America Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 7 North America Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 8 North America Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 9 North America Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 10 North America Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 11 North America Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 12 North America Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 13 North America Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 14 North America Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 15 North America Extracorporeal Membrane Oxygenation (Ecmo) In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 16 North America Tocilizumab In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 17 North America Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 18 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 19 North America Sepsis In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 20 North America Inhalation Of Harmful Substances In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 21 North America Severe Pneumonia In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 22 North America Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 23 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 24 North America Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 25 North America Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 26 North America Oral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 27 North America Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 28 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 29 North America Hospitals In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 30 North America Specialty Clinics In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 31 North America Home Healthcare In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 32 North America Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 33 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 34 North America Direct Tender In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 35 North America Hospital Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 36 North America Retail Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 37 North America Online Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 38 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Country, 2021-2030 (Usd Thousand)
Table 39 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 40 North America Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 41 North America Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 42 North America Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 43 North America Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 44 North America Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 45 North America Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 46 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 47 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 48 North America Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 49 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 50 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 51 U.S. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 52 U.S. Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 53 U.S. Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 54 U.S. Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 55 U.S. Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 56 U.S. Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 57 U.S. Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 58 U.S. Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 59 U.S. Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 60 U.S. Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 61 U.S. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 62 U.S. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 63 U.S. Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 64 U.S. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 65 U.S. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 66 Canada Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 67 Canada Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 68 Canada Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 69 Canada Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 70 Canada Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 71 Canada Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 72 Canada Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 73 Canada Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 74 Canada Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 75 Canada Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 76 Canada Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 77 Canada Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 78 Canada Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 79 Canada Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 80 Canada Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 81 Mexico Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 82 Mexico Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 83 Mexico Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 84 Mexico Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 85 Mexico Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 86 Mexico Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 87 Mexico Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 88 Mexico Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 89 Mexico Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 90 Mexico Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 91 Mexico Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 92 Mexico Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 93 Mexico Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 94 Mexico Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 95 Mexico Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
List Of Figures
Figure 1 North America Acute Respiratory Distress Syndrome (Ards) Market: Segmentation
Figure 2 North America Acute Respiratory Distress Syndrome (Ards) Market: Data Triangulation
Figure 3 North America Acute Respiratory Distress Syndrome (Ards) Market: Droc Analysis
Figure 4 North America Acute Respiratory Distress Syndrome (Ards) Market: North America Vs Regional Market Analysis
Figure 5 North America Acute Respiratory Distress Syndrome (Ards) Market: Company Research Analysis
Figure 6 North America Acute Respiratory Distress Syndrome (Ards) Market: Interview Demographics
Figure 7 North America Acute Respiratory Distress Syndrome (Ards) Market: Dbmr Market Position Grid
Figure 8 North America Acute Respiratory Distress Syndrome (Ards) Market: Market End User Coverage Grid
Figure 9 North America Acute Respiratory Distress Syndrome (Ards) Market: Vendor Share Analysis
Figure 10 North America Acute Respiratory Distress Syndrome (Ards) Market: Segmentation
Figure 11 Increasing Prevalence And Incidence Of Acute Lung Injury Are Expected To Drive The North America Acute Respiratory Distress Syndrome (Ards) Market In The Forecast Period Of 2022 To 2030
Figure 12 Mechanical Ventilation Segment Is Expected To Account For The Largest Share Of The North America Acute Respiratory Distress Syndrome (Ards) Market In 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Duchenne Muscular Dystrophy Treatment Market
Figure 14 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Type, 2022
Figure 15 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Type, 2023-2030 (Usd Thousand)
Figure 16 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Type, Cagr (2023-2030)
Figure 17 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Type, Lifeline Curve
Figure 18 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Cause, 2022
Figure 19 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Cause, 2023-2030 (Usd Thousand)
Figure 20 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Cause, Cagr (2023-2030)
Figure 21 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Cause, Lifeline Curve
Figure 22 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Route Of Administration, 2022
Figure 23 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Route Of Administration, 2023-2030 (Usd Thousand)
Figure 24 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Route Of Administration, Cagr (2023-2030)
Figure 25 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Route Of Administration, Lifeline Curve
Figure 26 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By End User, 2022
Figure 27 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By End User, 2023-2030 (Usd Thousand)
Figure 28 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By End User, Cagr (2023-2030)
Figure 29 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By End User, Lifeline Curve
Figure 30 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Distribution Channel, 2022
Figure 31 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
Figure 32 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Distribution Channel, Cagr (2023-2030)
Figure 33 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Distribution Channel, Lifeline Curve
Figure 34 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: Snapshot (2022)
Figure 35 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market: Company Share 2022 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us